Download - Stern Fact Sheet

Transcript

Stern Investor Relations is a leading investor relations (IR) firm specializing in providing IR consulting services to biotechnology and healthcare companies in the U.S. and around the world. Since our inception in 1998, we have worked with over 200 companies in all stages of development and in a wide range of clinical indications, including bellwethers in the industry, small- and mid-cap companies, recent IPOs and private companies.

• We possess an extensive, detailed and up-to-the-minute knowledge of the

sector, regulatory issues and the current market environment.

• We closely monitor industry trends to provide a comprehensive approach

to investor relations counsel.

Specialization in Healthcare IR

Relationships with the Investment Community• We have cultivated many valuable relationships within the investment

community and know the major players and industry events.

• We facilitate introductions with crucial contacts on Wall Street and help

our clients develop and improve existing relationships.

Focus on Best Industry Practice• We believe that high-quality companies should operate their IR programs

according to current best industry practice.

• We advise our clients accordingly, helping them convey news and

information to research analysts and investors regularly and consistently,

with special attention to timing, positioning, accuracy and fair disclosure

policies.

Our ultimate goal is to help each client realize a valuation that best reflects

the company’s assets and the internal value of the company through favor-

able interactions with the investment community.

We believe that a successful investor relations program depends on a multifaceted approach, including effective strategy and also tactical execu-

tion. Thoughtful strategic advice, commitment to execution and a careful

attention to detail are central to our approach.

We aim to provide cost-effective investor relations counsel and support and

to maximize the impact of our clients’ time and effort.

ApproAch

clientsACCeleROn PHARmA, InC.ACORdA THeRAPeUTICS InC.AlkeRmeS, InC.AlnylAm PHARmACeUTICAlS, InC.AmAG PHARmACeUTICAlS, InC.ARCHemIx CORP.BIOSPeCIFICS TeCHnOlOGIeS CORP.CURIS, InC.ImmUnOGen, InC.InTeRleUkIn GeneTICS, InC.IROnWOOd PHARmACeUTICAlS, InC.lUx BIOSCIenCeS, InC.mIllennIUm: THe TAkedA OnCOlOGy COmPAny mOmenTA PHARmACeUTICAlS, InC.TOkAI PHARmACeUTICAlS, InC.VeRenIUm CORPORATIOn

Stern Investor Relations, Inc. ■ new york, ny ■ 212.362.1200 ■ [email protected] ■ Copyright 2009

Tactical IR • We provide full tactical and event planning support, assisting with

various IR events, including roadshows (sell-side, bank-sponsored,

non-deal and investor conferences), Analyst and Investor days and

events, earnings and news announcements and events at medical

meetings.

• We assist with the development of news releases, fact sheets,

FAQs, annual reports and other IR-related documents.

Our team of experienced, analytical, IR professionals offers a

proven track record of delivering results. years of experience and

superior client service allow us to provide sophisticated and critical

direction, unique insights and a total perspective to meet clients’

needs.

lilian Stern, Principal and Founder, has been a senior IR

counselor in the biotechnology industry for over 15 years,

representing more than 200 companies. Prior to founding Stern

IR, lilian established and ran the investor relations group at Burns

mcClellan for six years and worked as a biotechnology sell-side

analyst at donaldson, lufkin & Jenrette/Credit Suisse First Bos-

ton. She holds an A.B. with distinction from Cornell University and

a J.d. with honors from Harvard law School.

teAMserVicesWorking closely with each client, we develop and execute custom-

ized strategic investor relations programs designed to manage com-

munications effectively with the investment community. Committed

to superior client service, we provide each client with senior level

attention, strategic counsel and critical, disciplined tactical support.

Stern IR offers a broad range of investor relations services that often

includes working with senior management to achieve key investor

relations goals, such as effective positioning, enhancing visibility,

improving institutional ownership and sell-side coverage, preparing

for financings and IPOs, developing good guidance practices and

managing communications around m&A, binary events and other

strategic issues.

Strategic IR• We emphasize the importance of strategic planning. each

relationship begins with an analysis of the client’s investment

considerations, including perceived strengths and challenges and

upcoming news items and milestones.

• We then develop documents to help guide our communications

and outreach strategies, including corporate messaging, a client-

catered yearly calendar, an outreach plan and a sophisticated

analyst and investor targeting analysis program.

Stern Investor Relations, Inc. ■ new york, ny ■ 212.362.1200 ■ [email protected] ■ Copyright 2009


Top Related